196 related articles for article (PubMed ID: 10834175)
1. [Changes of serum hepatocyte growth factor in coronary artery disease].
Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor and vascular endothelial growth factor in ischaemic heart disease.
Suzuki H; Murakami M; Shoji M; Iso Y; Kondo T; Shibata M; Ezumi H; Hamazaki Y; Koba S; Katagiri T
Coron Artery Dis; 2003 Jun; 14(4):301-7. PubMed ID: 12826929
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Sasayama S
Biochem Biophys Res Commun; 1996 Apr; 221(2):391-5. PubMed ID: 8619866
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
Yang ZJ; Xu SL; Chen B; Zhang SL; Zhang YL; Wei W; Ma DC; Wang LS; Zhu TB; Li CJ; Wang H; Cao KJ; Gao W; Huang J; Ma WZ; Wu ZZ
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239
[TBL] [Abstract][Full Text] [Related]
5. [Significance of hepatocyte growth factor measurement in patients with acute myocardial infarction].
Sato T; Yoshinouchi T; Sugimoto T; Sakamoto T; Fujieda H; Sato H; Murao S; Kobayashi H; Ohe T
J Cardiol; 1998 Aug; 32(2):77-82. PubMed ID: 9752615
[TBL] [Abstract][Full Text] [Related]
6. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin.
Matsumori A; Ono K; Okada M; Miyamoto T; Sato Y; Sasayama S
J Mol Cell Cardiol; 1998 Oct; 30(10):2145-9. PubMed ID: 9799666
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
Seko Y; Fukuda S; Nagai R
Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
[TBL] [Abstract][Full Text] [Related]
8. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis.
Güray U; Erbay AR; Güray Y; Yilmaz MB; Boyaci AA; Sasmaz H; Korkmaz S; Kütük E
Int J Cardiol; 2004 Aug; 96(2):235-40. PubMed ID: 15262039
[TBL] [Abstract][Full Text] [Related]
9. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance.
Kranz A; Rau C; Kochs M; Waltenberger J
J Mol Cell Cardiol; 2000 Jan; 32(1):65-72. PubMed ID: 10652191
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy.
Molnar C; Buratti T; Wiedermann CJ; Tilg H
Eur Cytokine Netw; 2000 Mar; 11(1):87-90. PubMed ID: 10705304
[TBL] [Abstract][Full Text] [Related]
11. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
13. Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer.
Wang W; Yang ZJ; Ma DC; Wang LS; Xu SL; Zhang YR; Cao KJ; Zhang FM; Ma WZ
Acta Pharmacol Sin; 2006 May; 27(5):555-60. PubMed ID: 16626510
[TBL] [Abstract][Full Text] [Related]
14. Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Heart Vessels; 2000; 15(3):105-11. PubMed ID: 11289497
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor production may be related to the inflammatory response in patients with acute myocardial infarction.
Shimada Y; Yoshiyama M; Jissho S; Kamimori K; Nakamura Y; Iida H; Takeuchi K; Yoshikawa J
Circ J; 2002 Mar; 66(3):253-6. PubMed ID: 11922273
[TBL] [Abstract][Full Text] [Related]
16. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease].
Gao B; Li ZC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction].
Deng ZR; Yang C; Ma AQ; Chen XY; Geng T
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1637-40. PubMed ID: 17121721
[TBL] [Abstract][Full Text] [Related]
18. [Serum soluble CD40L level and its application in coronary heart disease].
Li J; Peng DQ; Zhao SP
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):611-4. PubMed ID: 15804073
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
20. Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention.
Miyoshi T; Hirohata S; Uesugi T; Hirota M; Ohnishi H; Nogami K; Hatanaka K; Ogawa H; Usui S; Kusachi S
Clin Chim Acta; 2009 Mar; 401(1-2):3-7. PubMed ID: 19028479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
